_id
69105690ccc777a4e85d5630
Ticker
CTNM
Name
Contineum Therapeutics, Inc. Class A Common Stock
Exchange
NASDAQ
Address
3565 General Atomics Court, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.contineum-tx.com
Description
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis, progressive multiple sclerosis, and chronic pain. It also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor which is in Phase 2 clinical trial to treat depression and relapse remitting MS; and CTX-343, a peripherally restricted LPA1R antagonist which is a brain penetrant drug candidate. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.
Last Close
11.46
Volume
186906
Current Price
10
Change
0.03
Last Updated
2026-01-02T12:09:16.618Z
Image
data:image/webp;base64,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
Ipo Date
2024-04-05T00:00:00.000Z
Market Cap
417531616
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.827
Sentiment Sources
1
Rating
4.6
Target Price
21.8333
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
81000
Gross Profit
-81000
Operating Expenses
14851000
Operating Income
-14932000
Interest Expense
-
Pretax Income
-12792000
Net Income
-12792000
Eps
-0.45497957215701434
Dividends Per Share
-
Shares Outstanding
30446111
Income Tax Expense
-
EBITDA
-12711000
Operating Margin
-
Total Other Income Expense Net
2140000
Cash
42633000
Short Term Investments
139774000
Receivables
-
Inventories
-
Total Current Assets
184927000
Property Plant Equipment
5654000
Total Assets
190847000
Payables
786000
Short Term Debt
1477000
Long Term Debt
-
Total Liabilities
10377000
Equity
180470000
Bs_currency_symbol
USD
Depreciation
81000
Change In Working Capital
-2292000
Cash From Operations
-12197000
Capital Expenditures
98000
Cash From Investing
14941000
Cash From Financing
19105000
Net Change In Cash
21849000
Cf_currency_symbol
USD
PE
-
PB
1.5579070205574335
ROE
-7.088158696736299
ROA
-6.7027514186756925
FCF
-12295000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
81000
Quarters > 0 > income Statement > gross Profit
-81000
Quarters > 0 > income Statement > operating Expenses
14851000
Quarters > 0 > income Statement > operating Income
-14932000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-12792000
Quarters > 0 > income Statement > net Income
-12792000
Quarters > 0 > income Statement > eps
-0.45497957215701434
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
28115548
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-12711000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2140000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
42633000
Quarters > 0 > balance Sheet > short Term Investments
139774000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
184927000
Quarters > 0 > balance Sheet > property Plant Equipment
5654000
Quarters > 0 > balance Sheet > total Assets
190847000
Quarters > 0 > balance Sheet > payables
786000
Quarters > 0 > balance Sheet > short Term Debt
1477000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10377000
Quarters > 0 > balance Sheet > equity
180470000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-12792000
Quarters > 0 > cash Flow > depreciation
81000
Quarters > 0 > cash Flow > change In Working Capital
-2292000
Quarters > 0 > cash Flow > cash From Operations
-12197000
Quarters > 0 > cash Flow > capital Expenditures
98000
Quarters > 0 > cash Flow > cash From Investing
14941000
Quarters > 0 > cash Flow > cash From Financing
19105000
Quarters > 0 > cash Flow > net Change In Cash
21849000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.45497957215701434
Quarters > 0 > ratios > PB
1.5579070205574335
Quarters > 0 > ratios > ROE
-7.088158696736299
Quarters > 0 > ratios > ROA
-6.7027514186756925
Quarters > 0 > ratios > FCF
-12295000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
79000
Quarters > 1 > income Statement > gross Profit
-79000
Quarters > 1 > income Statement > operating Expenses
17823000
Quarters > 1 > income Statement > operating Income
-17902000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-16040000
Quarters > 1 > income Statement > net Income
-16040000
Quarters > 1 > income Statement > eps
-0.619400775316771
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
25895996
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-15961000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1862000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
20784000
Quarters > 1 > balance Sheet > short Term Investments
154700000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
176839000
Quarters > 1 > balance Sheet > property Plant Equipment
5863000
Quarters > 1 > balance Sheet > total Assets
182888000
Quarters > 1 > balance Sheet > payables
2001000
Quarters > 1 > balance Sheet > short Term Debt
1466000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
11498000
Quarters > 1 > balance Sheet > equity
171390000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-16040000
Quarters > 1 > cash Flow > depreciation
79000
Quarters > 1 > cash Flow > change In Working Capital
-1934000
Quarters > 1 > cash Flow > cash From Operations
-15661000
Quarters > 1 > cash Flow > capital Expenditures
44000
Quarters > 1 > cash Flow > cash From Investing
13884000
Quarters > 1 > cash Flow > cash From Financing
91000
Quarters > 1 > cash Flow > net Change In Cash
-1686000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.619400775316771
Quarters > 1 > ratios > PB
1.5109397281054904
Quarters > 1 > ratios > ROE
-9.358772390454519
Quarters > 1 > ratios > ROA
-8.77039499584445
Quarters > 1 > ratios > FCF
-15705000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
18110000
Quarters > 2 > income Statement > operating Income
-18110000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-15990000
Quarters > 2 > income Statement > net Income
-15990000
Quarters > 2 > income Statement > eps
-0.6181158984705014
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
25868935
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-18032000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2120000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
22470000
Quarters > 2 > balance Sheet > short Term Investments
168240000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
192134000
Quarters > 2 > balance Sheet > property Plant Equipment
6126000
Quarters > 2 > balance Sheet > total Assets
198264000
Quarters > 2 > balance Sheet > payables
3645000
Quarters > 2 > balance Sheet > short Term Debt
1455000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
13496000
Quarters > 2 > balance Sheet > equity
184768000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-15990000
Quarters > 2 > cash Flow > depreciation
78000
Quarters > 2 > cash Flow > change In Working Capital
-1082000
Quarters > 2 > cash Flow > cash From Operations
-14412000
Quarters > 2 > cash Flow > capital Expenditures
47000
Quarters > 2 > cash Flow > cash From Investing
14915000
Quarters > 2 > cash Flow > cash From Financing
24000
Quarters > 2 > cash Flow > net Change In Cash
527000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6181158984705014
Quarters > 2 > ratios > PB
1.4000765825251127
Quarters > 2 > ratios > ROE
-8.654095947350191
Quarters > 2 > ratios > ROA
-8.06500423677521
Quarters > 2 > ratios > FCF
-14459000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
242000
Quarters > 3 > income Statement > cost Of Revenue
121000
Quarters > 3 > income Statement > gross Profit
121000
Quarters > 3 > income Statement > operating Expenses
-84741000
Quarters > 3 > income Statement > operating Income
84741000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-14565000
Quarters > 3 > income Statement > net Income
-14565000
Quarters > 3 > income Statement > eps
-0.5633438046047525
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
25854549
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-14490000
Quarters > 3 > income Statement > operating Margin
35016.94214876033
Quarters > 3 > income Statement > total Other Income Expense Net
-99306000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
21943000
Quarters > 3 > balance Sheet > short Term Investments
182817000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
206388000
Quarters > 3 > balance Sheet > property Plant Equipment
6456000
Quarters > 3 > balance Sheet > total Assets
212847000
Quarters > 3 > balance Sheet > payables
1811000
Quarters > 3 > balance Sheet > short Term Debt
1452000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
14781000
Quarters > 3 > balance Sheet > equity
198066000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14565000
Quarters > 3 > cash Flow > depreciation
75000
Quarters > 3 > cash Flow > change In Working Capital
2950000
Quarters > 3 > cash Flow > cash From Operations
-10202000
Quarters > 3 > cash Flow > capital Expenditures
166000
Quarters > 3 > cash Flow > cash From Investing
-9388000
Quarters > 3 > cash Flow > cash From Financing
642000
Quarters > 3 > cash Flow > net Change In Cash
-18948000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5633438046047525
Quarters > 3 > ratios > PB
1.3053501863015358
Quarters > 3 > ratios > ROE
-7.353609402926297
Quarters > 3 > ratios > ROA
-6.84294352281216
Quarters > 3 > ratios > FCF
-10368000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-42.84297520661157
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
258000
Annuals > 0 > income Statement > gross Profit
-258000
Annuals > 0 > income Statement > operating Expenses
50636000
Annuals > 0 > income Statement > operating Income
-50894000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-42258000
Annuals > 0 > income Statement > net Income
-42258000
Annuals > 0 > income Statement > eps
-2.183553344753868
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
19352859
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-42000000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
8636000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
21943000
Annuals > 0 > balance Sheet > short Term Investments
182817000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
206388000
Annuals > 0 > balance Sheet > property Plant Equipment
6456000
Annuals > 0 > balance Sheet > total Assets
212847000
Annuals > 0 > balance Sheet > payables
1811000
Annuals > 0 > balance Sheet > short Term Debt
1452000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
14781000
Annuals > 0 > balance Sheet > equity
198066000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-42258000
Annuals > 0 > cash Flow > depreciation
258000
Annuals > 0 > cash Flow > change In Working Capital
5334000
Annuals > 0 > cash Flow > cash From Operations
-32845000
Annuals > 0 > cash Flow > capital Expenditures
514000
Annuals > 0 > cash Flow > cash From Investing
-69739000
Annuals > 0 > cash Flow > cash From Financing
109001000
Annuals > 0 > cash Flow > net Change In Cash
6417000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.183553344753868
Annuals > 0 > ratios > PB
1.1168154977128837
Annuals > 0 > ratios > ROE
-21.335312471600375
Annuals > 0 > ratios > ROA
-19.853697726535962
Annuals > 0 > ratios > FCF
-33359000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
50000000
Annuals > 1 > income Statement > cost Of Revenue
195000
Annuals > 1 > income Statement > gross Profit
50000000
Annuals > 1 > income Statement > operating Expenses
66077000
Annuals > 1 > income Statement > operating Income
-16077000
Annuals > 1 > income Statement > interest Expense
208000
Annuals > 1 > income Statement > pretax Income
23170000
Annuals > 1 > income Statement > net Income
22720000
Annuals > 1 > income Statement > eps
0.8987728585787237
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
25278912
Annuals > 1 > income Statement > income Tax Expense
450000
Annuals > 1 > income Statement > EBITDA
23573000
Annuals > 1 > income Statement > operating Margin
-32.153999999999996
Annuals > 1 > income Statement > total Other Income Expense Net
39247000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
15526000
Annuals > 1 > balance Sheet > short Term Investments
109664000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
127706000
Annuals > 1 > balance Sheet > property Plant Equipment
1397000
Annuals > 1 > balance Sheet > total Assets
130386000
Annuals > 1 > balance Sheet > payables
635000
Annuals > 1 > balance Sheet > short Term Debt
464000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
198322000
Annuals > 1 > balance Sheet > equity
-67936000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
22720000
Annuals > 1 > cash Flow > depreciation
195000
Annuals > 1 > cash Flow > change In Working Capital
-1024000
Annuals > 1 > cash Flow > cash From Operations
19349000
Annuals > 1 > cash Flow > capital Expenditures
414000
Annuals > 1 > cash Flow > cash From Investing
-65568000
Annuals > 1 > cash Flow > cash From Financing
56176000
Annuals > 1 > cash Flow > net Change In Cash
9957000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.8987728585787237
Annuals > 1 > ratios > PB
-4.253090617051343
Annuals > 1 > ratios > ROE
-33.44324069712671
Annuals > 1 > ratios > ROA
17.425183685364992
Annuals > 1 > ratios > FCF
18935000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.3787
Annuals > 1 > health Score
58
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
329000
Annuals > 2 > income Statement > gross Profit
-329000
Annuals > 2 > income Statement > operating Expenses
22391000
Annuals > 2 > income Statement > operating Income
-22720000
Annuals > 2 > income Statement > interest Expense
388000
Annuals > 2 > income Statement > pretax Income
-24253000
Annuals > 2 > income Statement > net Income
-24253000
Annuals > 2 > income Statement > eps
-0.9650711338561183
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25130790
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-23536000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1533000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5569000
Annuals > 2 > balance Sheet > short Term Investments
41670000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
48392000
Annuals > 2 > balance Sheet > property Plant Equipment
2115000
Annuals > 2 > balance Sheet > total Assets
50636000
Annuals > 2 > balance Sheet > payables
430000
Annuals > 2 > balance Sheet > short Term Debt
5058000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
11366000
Annuals > 2 > balance Sheet > equity
39270000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-24253000
Annuals > 2 > cash Flow > depreciation
329000
Annuals > 2 > cash Flow > change In Working Capital
-1267000
Annuals > 2 > cash Flow > cash From Operations
-20121000
Annuals > 2 > cash Flow > capital Expenditures
118000
Annuals > 2 > cash Flow > cash From Investing
22299000
Annuals > 2 > cash Flow > cash From Financing
-1239000
Annuals > 2 > cash Flow > net Change In Cash
939000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.9650711338561183
Annuals > 2 > ratios > PB
7.314614965622613
Annuals > 2 > ratios > ROE
-61.75961293608352
Annuals > 2 > ratios > ROA
-47.896753298048814
Annuals > 2 > ratios > FCF
-20239000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
28647000
Annuals > 3 > income Statement > operating Income
-28647000
Annuals > 3 > income Statement > interest Expense
332000
Annuals > 3 > income Statement > pretax Income
-29001000
Annuals > 3 > income Statement > net Income
-29001000
Annuals > 3 > income Statement > eps
-1.1540027193733264
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25130790
Annuals > 3 > income Statement > income Tax Expense
241000
Annuals > 3 > income Statement > EBITDA
-28336000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-354000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4630000
Annuals > 3 > balance Sheet > short Term Investments
64373999
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
69779000
Annuals > 3 > balance Sheet > property Plant Equipment
642000
Annuals > 3 > balance Sheet > total Assets
70518000
Annuals > 3 > balance Sheet > payables
660000
Annuals > 3 > balance Sheet > short Term Debt
1250000
Annuals > 3 > balance Sheet > long Term Debt
3659000
Annuals > 3 > balance Sheet > total Liabilities
8930000
Annuals > 3 > balance Sheet > equity
61588000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-29001000
Annuals > 3 > cash Flow > depreciation
325000
Annuals > 3 > cash Flow > change In Working Capital
108000
Annuals > 3 > cash Flow > cash From Operations
-26266000
Annuals > 3 > cash Flow > capital Expenditures
168000
Annuals > 3 > cash Flow > cash From Investing
-64968000
Annuals > 3 > cash Flow > cash From Financing
79839000
Annuals > 3 > cash Flow > net Change In Cash
-11395000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.1540027193733264
Annuals > 3 > ratios > PB
4.663975607261155
Annuals > 3 > ratios > ROE
-47.08871858154186
Annuals > 3 > ratios > ROA
-41.12567004169148
Annuals > 3 > ratios > FCF
-26434000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.45497957215701434
Valuation > metrics > PB
1.5579070205574335
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-7.088158696736299
Profitability > metrics > ROA
-6.917324133306655
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05749986147282097
Risk > metrics > Interest Coverage
-184.34567901234567
Risk > final Score
-677
Risk > verdict
High
Liquidity > metrics > Current Ratio
81.71763146266018
Liquidity > metrics > Quick Ratio
81.71763146266018
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-846
Prev Risks > 1
25
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:40:14.084Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.45
Earnings History > 0 > eps Estimate
-0.6
Earnings History > 0 > eps Difference
0.15
Earnings History > 0 > surprise Percent
25
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.62
Earnings History > 1 > eps Estimate
-0.28
Earnings History > 1 > eps Difference
-0.34
Earnings History > 1 > surprise Percent
-121.4286
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.62
Earnings History > 2 > eps Estimate
-0.42
Earnings History > 2 > eps Difference
-0.2
Earnings History > 2 > surprise Percent
-47.619
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-06
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.56
Earnings History > 3 > eps Estimate
-0.43
Earnings History > 3 > eps Difference
-0.13
Earnings History > 3 > surprise Percent
-30.2326
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4
Earnings History > 4 > eps Estimate
-0.41
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
2.439
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.39
Earnings History > 5 > eps Estimate
-0.35
Earnings History > 5 > eps Difference
-0.04
Earnings History > 5 > surprise Percent
-11.4286
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-16
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-3.55
Earnings History > 6 > eps Estimate
-0.46
Earnings History > 6 > eps Difference
-3.09
Earnings History > 6 > surprise Percent
-671.7391
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-1.44
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-1.44
Earnings History > 7 > surprise Percent
-
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis, progressive multiple sclerosis, and chronic pain. It also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor which is in Phase 2 clinical trial to treat depression and relapse remitting MS; and CTX-343, a peripherally restricted LPA1R antagonist which is a brain penetrant drug candidate. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A$CTNM stock is up 15% today. Here's what we see in our data. Quiver Quantitative
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$21.8333
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Contineum Therapeutics, Inc. Class A Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.45
EPS Estimate
-0.6
EPS Difference
0.15
Surprise Percent
25%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.